Skip to content
★ Sign in to follow
PB
Total declarations
151
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (74 ops.)
€3.5M

Latest filing published 13 Jul 2017 for ChemoCentryx, Inc., €34k.

Filing timeline

BuySale
Petrus Bekker

Insider track record

Disclosed buys
0
Disclosed sells
74
Signal history

Petrus Bekker: trading record in brief

Petrus Bekker appears in our data through filings on ChemoCentryx, Inc. shares, published by SEC (Form 4). We count 151 filings; the first trade dates from 17 September 2012 and the latest from 13 July 2017.

Sales make up the whole of the open-market record (74 sales, €3.5M). The rest of the record consists of 1 share grant and 76 option exercises. In 2017 alone, the filings show no purchases and 15 sales.

Most recently, on 13 July 2017, the filings show an option exercise worth €56k in ChemoCentryx, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Petrus Bekker

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations148 total
  • ◇
    Chief Medical OfficerExecutivesChemoCentryx, Inc.
    38,581 USD11SEC
    6,124 shares@ US$6.301.0% of flowCommon StockSEC:0001209191-17-045120:0
  • ▼
    Chief Medical OfficerExecutivesChemoCentryx, Inc.
    56,953 USD11SEC
    6,124 shares@ US$9.301.5% of flowCommon StockSEC:0001209191-17-045120:1
  • ◇
    Chief Medical OfficerExecutivesChemoCentryx, Inc.
    164,744 USD11SEC
    23,876 shares@ US$6.904.3% of flowCommon StockSEC:0001209191-17-045120:2
  • ◇
    Chief Medical OfficerExecutivesChemoCentryx, Inc.
    7,875 USD11SEC
    1,250 shares@ US$6.300.2% of flowCommon StockSEC:0001209191-17-045120:6
  • ▼
    Chief Medical OfficerExecutivesChemoCentryx, Inc.
    12,500 USD11SEC
    1,250 shares@ US$10.000.3% of flowCommon StockSEC:0001209191-17-045120:7
  • ◇
    Chief Medical OfficerExecutivesChemoCentryx, Inc.
    63,846 USD11SEC
    9,253 shares@ US$6.901.7% of flowCommon StockSEC:0001209191-17-045120:8
  • ▼
    Chief Medical OfficerExecutivesChemoCentryx, Inc.
    91,790 USD11SEC
    9,253 shares@ US$9.922.4% of flowCommon StockSEC:0001209191-17-045120:9
  • ◇
    Chief Medical OfficerExecutivesChemoCentryx, Inc.
    49,679 USD11SEC
    6,997 shares@ US$7.101.3% of flowCommon StockSEC:0001209191-17-045120:10
  • ▼
    Chief Medical OfficerExecutivesChemoCentryx, Inc.
    69,970 USD11SEC
    6,997 shares@ US$10.001.8% of flowCommon StockSEC:0001209191-17-045120:11
  • ◇
    Chief Medical OfficerExecutivesChemoCentryx, Inc.
    20,475 USD11SEC
    2,500 shares@ US$8.190.5% of flowCommon StockSEC:0001209191-17-045120:12
  • ▼
    Chief Medical OfficerExecutivesChemoCentryx, Inc.
    25,000 USD11SEC
    2,500 shares@ US$10.000.7% of flowCommon StockSEC:0001209191-17-045120:13
  • ◇
    Chief Medical OfficerExecutivesChemoCentryx, Inc.
    27,605 USD11SEC
    3,888 shares@ US$7.100.7% of flowCommon StockSEC:0001209191-17-045120:14
  • ▼
    Chief Medical OfficerExecutivesChemoCentryx, Inc.
    39,969 USD11SEC
    3,888 shares@ US$10.281.0% of flowCommon StockSEC:0001209191-17-045120:15
  • ◇
    Chief Medical OfficerExecutivesChemoCentryx, Inc.
    99,304 USD11SEC
    12,125 shares@ US$8.192.6% of flowCommon StockSEC:0001209191-17-045120:16
  • ▼
    Chief Medical OfficerExecutivesChemoCentryx, Inc.
    123,554 USD11SEC
    12,125 shares@ US$10.193.2% of flowCommon StockSEC:0001209191-17-045120:17
  • ◇
    Chief Medical OfficerExecutivesChemoCentryx, Inc.
    60,000 USD11SEC
    10,000 shares@ US$6.001.6% of flowCommon StockSEC:0001209191-17-045120:4
  • ▼
    Chief Medical OfficerExecutivesChemoCentryx, Inc.
    100,000 USD11SEC
    10,000 shares@ US$10.002.6% of flowCommon StockSEC:0001209191-17-045120:5
  • ▼
    Chief Medical OfficerExecutivesChemoCentryx, Inc.
    236,372 USD12SEC
    23,876 shares@ US$9.906.2% of flowCommon StockSEC:0001209191-17-045120:3
  • ◇
    Chief Medical OfficerExecutivesChemoCentryx, Inc.
    123,398 USD11SEC
    19,587 shares@ US$6.303.2% of flowCommon StockSEC:0001209191-17-044704:0
  • ▼
    Chief Medical OfficerExecutivesChemoCentryx, Inc.
    182,159 USD11SEC
    19,587 shares@ US$9.304.8% of flowCommon StockSEC:0001209191-17-044704:1
  • ◇
    Chief Medical OfficerExecutivesChemoCentryx, Inc.
    1,827 USD11SEC
    290 shares@ US$6.300.0% of flowCommon StockSEC:0001209191-17-044704:2
  • ▼
    Chief Medical OfficerExecutivesChemoCentryx, Inc.
    2,697 USD11SEC
    290 shares@ US$9.300.1% of flowCommon StockSEC:0001209191-17-044704:3
  • ◇
    Chief Medical OfficerExecutivesChemoCentryx, Inc.
    213,000 USD12SEC
    30,000 shares@ US$7.105.6% of flowCommon StockSEC:0001209191-17-042617:0
  • ▼
    Chief Medical OfficerExecutivesChemoCentryx, Inc.
    273,600 USD12SEC
    30,000 shares@ US$9.127.2% of flowCommon StockSEC:0001209191-17-042617:1
  • ▼
    Chief Medical OfficerExecutivesChemoCentryx, Inc.
    50,187 USD11SEC
    5,509 shares@ US$9.111.3% of flowCommon StockSEC:0001209191-17-042617:3

25 of 148 declarations